News About: Pharm. Industry
Chong Kun Dang names new CEOChong Kun Dang Pharmaceutical Co. announced last Friday that incumbent Vice Chairman Kim Jung-woo will lead the Seoul-based drug manufacturer based on his 40-year background in ...
|
Huons files new PE drug application for marketing approval with KFDA
Huons announced last Friday that it has filed a marketing application for its new oral premature ejaculation (PE) drug (clomipramine HCl) with the Korea Food and Drug Administration.
Jointly developed by CTC Bio, c...
Competition to be seen intensifying over OTC market
A fierce battle is foreseen in the domestic market for over-the-counter (OTC) drugs, which has so far been neglected by local drugs makers, according to Yakup Shinmoon, a local trade paper.
To soften the government...
Testing of new combination drug approved by KFDA
Ildong Pharmaceutical said Wednesday it has received approval from the Korea Food and Drug Administration to conduct clinical trials of a combination drug for the treatment of hypertension and hyperlipidemia.
The d...
Hanmi set to go global
Local pharmaceutical companies are expanding their businesses abroad to enlarge and diversify their customer base while creating opportunities to improve their products through cooperation with foreign firms, industry...
Multinational firms’ R&D spending drops 2.2% in 2011
Multinational drug firms slightly cut back their spending on research and developing (R&D) last year, dampened by economic jitters stemming from a global slowdown, data showed Wednesday.
The combined R&D spending o...
Hanmi boosting R&D spending
Hanmi Pharmaceutical has been spending more on 20 research and development (R&D) projects to strengthen its technology leadership.
The company spent 41.7 billion won on R&D in the first half of this year, which acc...
Government to support CJ Pharma’s diabetes drug development
The pharmaceutical unit of CJ Cheil Jedang, the country’s largest food manufacturer, said Wednesday it plans to carry out local Phase I clinical trials for its new combination diabetes drug candidate as part of a gove...
Drug makers see their cash reserves piling up
A growing number of pharmaceutical firms piled up in the first half of this year, as they refrained from investing amid the worsening business slump, , data showed Tuesday.
The average cash reserve ratio of 52 list...
Ahngook signs drug deal with Takeda Korea
Ahngook Pharmaceutical said Tuesday it has signed an agreement with Takeda Korea in a move to exclusively distribute the latter’s Zycomb nasal spray solution here.
Zycomb is a combination medicinal product consisti...
